Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04167748 · ClinicalTrials.gov registry record · NA
Preimplantation Genetic Testing in Women of Advanced Maternal Age
A NA study of Infertility, Female, sponsored by Genomic Prediction.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT04167748: Recruiting NA study of Infertility, Female, sponsored by Genomic Prediction.
NCT04167748 is a NA study of Infertility, Female that is actively recruiting participants, run by Genomic Prediction. The registered enrollment target is 240 participants, below the 370-participant average among 18 other Infertility, Female trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04167748, a NA study of Infertility, Female, is actively recruiting participants, sponsored by Genomic Prediction.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.
Primary Outcome
Number of patients who experience an ongoing pregnancy rate (\>20 weeks of gestation) after their first embryo transfer
Conditions Studied
Interventions
- PROCEDURE Preimplantation genetic testing for aneuploidy (PGT-A)
Study Locations (1)
Florida
- IVF Florida Reproductive Associates - Margate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2021-03-05 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT04167748 shows while recruiting
NCT04167748 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 370-participant average among 18 other Infertility, Female trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Infertility, Female appearing as the primary indexed condition, and to 1 intervention - of which Preimplantation genetic testing for aneuploidy (PGT-A) is the first listed.
NCT04167748 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04167748 about?
NCT04167748 is a clinical study titled "Preimplantation Genetic Testing in Women of Advanced Maternal Age". The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.
What is the current status of trial NCT04167748?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2021-03-05. Estimated completion is 2026-12.
What conditions does trial NCT04167748 study?
This clinical trial studies the following conditions: Infertility, Female.
What interventions are being tested in trial NCT04167748?
The interventions under investigation include: Preimplantation genetic testing for aneuploidy (PGT-A) (PROCEDURE).
Who is sponsoring clinical trial NCT04167748?
This trial is sponsored by Genomic Prediction, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04167748 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility, Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04167748's enrollment target sits among peer trials
240 4th of 18 higher than 14 of 18 other Infertility, Female trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility, Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial
RECRUITING · NA
-
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
RECRUITING · NA
-
Ovarian Tissue Cryopreservation
RECRUITING · NA
-
The Effect of a Mindset Management Approach on Stress Levels in Women With Infertility
RECRUITING · NA
-
SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques
RECRUITING · NA
-
UTERINE EVALUATION FOR THE IDENTIFICATION OF PATHOLOGY. This Study Will Compare the Intrauterine Pathology Detection Rate Between Standard of Care Hydrosonography, and a New Visual Saline Infusion Device Providing Direct Visualization of the Uterus.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI